Actively Recruiting
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
Led by University of California, San Diego · Updated on 2022-06-07
70
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.
CONDITIONS
Official Title
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing hepatic resection
- Admitting service requests Acute Pain Service consult
- Age over 18 years and able to provide consent
You will not qualify if you...
- Pregnancy
- Incarceration
- Unable to communicate with investigators and hospital staff
- Severe hepatic disease
- Chronic high-dose opioid use (daily use for more than 4 weeks before surgery of at least 20 mg oxycodone equivalent)
- Body mass index (BMI) over 40 kg/m2
- Allergy to lidocaine or ropivacaine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Diego
San Diego, California, United States, 92103
Actively Recruiting
Research Team
E
Engy T Said, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here